Osaic Holdings
NVO

Osaic Holdings’s Novo Nordisk NVO Stock Holding History

Osaic Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
6
+5
+500% +$215 ﹤0.01% 6472
2026
Q1 		$1.25K Sell
1
-35
-97% -$1.66K ﹤0.01% 7194
2025
Q4 		$540 Buy
36
+35
+3,500% +$1.79K ﹤0.01% 7426
2025
Q3 		$183 Hold
1
– – ﹤0.01% 7702
2025
Q2 		$700 Hold
1
– – ﹤0.01% 7273
2025
Q1 		$975 Sell
1
-75
-99% -$6.19K ﹤0.01% 6823
2024
Q4 		$90K Buy
76
+69
+986% +$7.46K ﹤0.01% 4263
2024
Q3 		$5.29K Buy
7
+1
+17% +$133 ﹤0.01% 6162
2024
Q2 		$12.2K Sell
6
-1
-14% -$133 ﹤0.01% 5663
2024
Q1 		$10.8K Buy
7
+6
+600% +$714 ﹤0.01% 5706
2023
Q4 		$3.61K Buy
+1
New +$99 ﹤0.01% 6299

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Osaic Holdings's NVO Position: Q2 2026 in Review

Osaic Holdings reduced its Novo Nordisk (NVO) stake by 5.4% in Q2 2026, selling an estimated $800K and leaving 323,855 shares worth $15.5M. The position accounts for 0.02% of the portfolio, ranked #780.

Osaic Holdings first reported a position in NVO in Q1 2020 and has held it in 26 quarters since. The position peaked at $58.7M in Q3 2023. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Osaic Holdings held 323,855 shares of Novo Nordisk worth $15.5M as of Q2 2026.
  • Osaic Holdings sold 18,622 Novo Nordisk shares in Q2 2026, an estimated $800K.
  • Novo Nordisk made up 0.02% of Osaic Holdings's portfolio in Q2 2026, its #780 holding.
  • Osaic Holdings first reported a position in Novo Nordisk in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Novo Nordisk position peaked at $58.7M in Q3 2023.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.